SINEUPs: a novel toolbox for RNA therapeutics

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• RNA therapeutics are expanding the scope of druggable genomic targets.
• Long non-coding RNAs (lncRNAs) represent a rich source for novel RNA-based drugs due to their modular structures and functions.
• lncRNAs can be engineered to recruit protein cofactors or interact with nucleic acids.

Purpose of the Study:

• To review the current understanding of SINEUPs (natural antisense lncRNAs).
• To discuss the potential therapeutic applications of SINEUPs in diseases.
• To highlight the mechanism by which SINEUPs enhance protein translation.

Main Methods:

• Identification and characterization of SINEUPs as a new class of functional lncRNAs.
• Analysis of SINEUP structure, including effector and binding domains.
• Review of genetic engineering strategies for synthetic SINEUP development.

Main Results:

• SINEUPs are natural antisense lncRNAs that enhance the translation of overlapping mRNAs.
• They possess a dual-domain structure: an effector domain (SINEB2 element) for translation enhancement and a binding domain for target specificity.
• Synthetic SINEUPs can be engineered to target any mRNA, increasing endogenous protein levels.

Conclusions:

• SINEUPs represent a promising new class of RNA therapeutics.
• Their ability to boost protein translation offers therapeutic potential for diseases requiring increased endogenous protein expression.
• Further research into synthetic SINEUPs could lead to novel treatments for various conditions.